Harris Williams Advises RQM+ on its Sale to Linden Capital Partners
Summary
The transaction was led by Paul Hepper, Nick Owens and Nathan Robertson of the Harris Williams Healthcare & Life Sciences (HCLS) Group. DFW is backed by both institutional and high net worth individual investors and has established a more than 20-year track record of success in building leading companies. Linden’s strategy is based upon three elements: healthcare specialization, integrated private equity and operating experience, and its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical and services segments of healthcare. Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses.